PDCD1 and neoplasm: Compared to the vector controls or mutp53-R175H-bearing 4T1 tumors, the tumor-infiltrating CD8+ T cell populations were significantly increased in mutp53-R273H-bearing 4T1 tumors, especially after anti-PD-1 treatment (Fig. 8E).